AKASA vs Collectly (2026)
Two products chasing the same revenue from opposite ends of the ledger. AKASA works the payer side, running one engine across coding, documentation integrity and claim work so the claim goes out right and gets paid. Collectly works the patient side, where deductibles have turned a minor line into a large share of provider revenue and collection fails for behavioural reasons rather than technical ones. Look at an ageing report before choosing, because the answer is usually visible there: if denials and payer lag dominate, AKASA reaches the bigger pool, and if the uncollected balance is increasingly owed by patients, no amount of claim automation touches it. Ask Collectly whether you are paying a fee or a share of what is recovered.
- One engine spans coding, clinical documentation integrity and the claim work around them, which is the payer facing half of the receivable.
- The longer commercial track record in generative revenue cycle work matters for a function touching every encounter.
- For a health system, standardising the claim side on one vendor reduces the handoffs where errors accumulate.
- It works the patient responsibility portion, which has grown into a large share of provider revenue and fails for behavioural rather than technical reasons.
- The buyer is the provider and the outcome is cash recovered from balances patients can pay but have not.
- For an organisation whose ageing receivable is increasingly consumer owed, no amount of claim automation reaches it.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. AKASA and Collectly are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | AKASA | Collectly |
|---|---|---|
| Primary category | RCM & Prior Auth AI | RCM & Prior Auth AI |
| Headquarters | South San Francisco, California | Santa Monica, California |
| Website | akasa.com | collectly.co |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards AKASA its top capability grade on AI Centrality, Security Certifications and Trust Center and Setting and Specialty Coverage. Set against Collectly, AKASA grades higher on several axes, including AI Centrality, Model and Technology Transparency and AI Safety and PHI Stewardship. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index awards Collectly its top capability grade on Security Certifications and Trust Center, EHR and Interoperability Depth and Setting and Specialty Coverage. Set against AKASA, Collectly grades higher on EHR and Interoperability Depth. Its thinnest published disclosure sits on AI Liability and Recourse. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose AKASA or Collectly?
On the axes where the AI Health Index separates them, AKASA grades higher on several axes, including AI Centrality, Model and Technology Transparency and AI Safety and PHI Stewardship, and Collectly grades higher on EHR and Interoperability Depth. AKASA leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do AKASA and Collectly differ most?
The widest separation the AI Health Index records between AKASA and Collectly is on AI Centrality, where AKASA grades A and Collectly grades B. That axis sits in the AI Capability group, so it should carry the most weight for a buyer whose binding constraint is how much of the work the model itself is trusted to do.
Where do AKASA and Collectly grade the same?
The AI Health Index grades AKASA and Collectly the same on several axes, including Autonomy and Oversight Model, Model Supply Chain Disclosure and Clinical and Operational Evidence. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
What have AKASA and Collectly not disclosed?
At the last review, at least one of AKASA and Collectly published thin or absent detail on AI Liability and Recourse. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the RCM & Prior Auth AI page.
These work opposite halves of the same receivable and most growing organisations need both, so the useful analysis is where the cash is actually stuck rather than which product is better. Collections is frequently priced as a share of recovered cash, which rewards contact volume, and neither vendor publishes subgroup performance, which matters because outreach that performs unevenly lands hardest on patients least able to absorb a balance. Neither publishes an independent evaluation of its returns.